Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Healthcare
Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Verisante Technology Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by firesIayer96on Oct 24, 2012 6:55pm
229 Views
Post# 20520356

RE: RE: RE: RE: Forbes.com

RE: RE: RE: RE: Forbes.com

gaserx2,

I know you aren't being truly serious but I really hope we are never in the position where MELA is able to buy us out.

I think Novadaq is a much more realistic possibility. NDQ currently have $40m cash (roughly the current VRS market cap) , a $1/2B market cap and the NDQ western offices are only blocks away from VRS' Richmond engineering facility.

Novadaq reported total second quarter 2012 revenue of $5.4 million, up approximately 48%. I'm looking forward to seeing revenue numbers when NDQ reports Q3 financial results on Nov 2.

Of course NDQ is quite familiar with BCCA affiliated  spinoffs. NDQ purchased all the assets to Xillix in 2007 for $3m. Dr. Branko Palcic and Dr. Stephen Lam were both involved with several of the Xillix technological patents, etc. Dr. Palcic is currently on the VRS Product Development Team, and Dr. Lam is co-inventor of the Verisante Core.

Just my thoughts.

 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities